Enliven Therapeutics, Inc.ELVNNASDAQ
Loading
Net worth of the company (assets minus liabilities)
5Y CAGR
+40.3%/yr
Long-term compound
Percentile
P100
Near historical high
vs 5Y Ago
5.4x
Strong expansion
Streak
3 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $459.60M | +48.3% |
| 2024 | $309.85M | +26.0% |
| 2023 | $245.91M | +420.1% |
| 2022 | $-76.83M | -171.9% |
| 2021 | $106.86M | +26.6% |
| 2020 | $84.44M | +272.9% |
| 2019 | $-48.85M | -85.6% |
| 2018 | $-26.32M | -69.4% |
| 2017 | $-15.53M | - |